Geoffrey C. Wall, PharmD, FCCP, BCPS

home / authors / geoffrey-c-wall-pharmd-fccp-bcps

Articles

Novel Therapies in Atopic Dermatitis

Geoffrey C. Wall, PharmD, FCCP, BCPS;Catherine Defino

September 3rd 2017

Atopic dermatitis (AD) is among the most common chronic inflammatory skin disorders in the Western world, with studies suggesting that 10.7% of the US population is affected.

Contact Dermatitis

Geoffrey C. Wall, PharmD, FCCP, BCPS;Julianne Schlichting

September 3rd 2017

Contact dermatitis is among the most common inflammatory skin conditions encountered by clinicians.

Published: May 30th 2025 | Updated: June 5th 2025

Emerging Data: Impacts of ROCKstar and AGAVE-201

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com

Published: April 18th 2025 | Updated: April 21st 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com

Published: March 10th 2025 | Updated: March 21st 2025

Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM

Image credit: toeytoey | stock.adobe.com

Published: March 12th 2025 | Updated: March 18th 2025

MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations

Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com

Published: February 26th 2025 | Updated: March 14th 2025

Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management

fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com

Published: March 7th 2025 | Updated: March 10th 2025

FDA Approves Interchangeable Biosimilar to Xolair

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Geoffrey C. Wall, PharmD, FCCP, BCPS

Articles

Latest Updated Articles